This Article Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, J. Articles by Hansen, P. D. Search for Related Content PubMed PubMed Citation Articles by Cheng, J. Articles by Hansen, P. D.

Laparoscopic Placement of Hepatic Artery Infusion Pumps: Technical Considerations and Early Results

From the Department of Minimally Invasive Surgery, Legacy Health System, Portland, Oregon.

Correspondence: Address correspondence and reprint requests to: Paul D. Hansen, MD, General Surgery, TC-29260, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, MI 48109; e-mail: pdhmd{at}aol.com

Background: Laparoscopic hepatic artery infusion pump (LHAIP) placement is a novel treatment option for patients with colorectal liver metastases. This study investigates technical difficulties with regard to variant hepatic arteries and the preliminary outcomes for patients treated with LHAIP placement.

Methods: Between March 1998 and January 2003, 38 patients with colorectal metastases confined to the liver, 35 (92%) of who had prior systemic chemotherapy that failed, were treated with LHAIP.

Results: Twelve patients (32%) had LHAIP placement only, and 26 (68%) had pump placement combined with laparoscopic radiofrequency ablation (LRFA; 24 patients) and/or liver resection (2 patients). Variant hepatic arterial (HA) anatomy was present in 18 patients (47%). The presence of a variant HA did not increase pump complications, operative time, or blood loss (P .20) or decrease the functional time of pump use (P = .91) in comparison with normal anatomy. In all patients with a variant HA, laparoscopic ligation of the variant vessel and/or cannulation of nongastroduodenal artery resulted in complete hepatic perfusion. Three misperfusions identified intraoperatively with use of methylene blue injection were corrected by laparoscopic ligation (two) or postoperative angioembolization (one). Postoperative pump radionuclide flow studies confirmed isolated hepatic artery infusion in all cases. There was a 13% pump-related complication rate. During a median follow-up of 11 months (0.5 to 35.5 months), the actuarial rate of overall survival was 47% and the estimated median survival time was 17.5 months.

Conclusions: LHAIP placement is technically feasible, and variant HA is not associated with increased pump complications or decreased pump functional time.

Key Words: Colorectal liver metastases • Hepatic artery infusion pump • Laparoscopy

This article has been cited by other articles:

				E. S. Ong, M. Poirier, and N. J. Espat Hepatic Intra-Arterial Chemotherapy Ann. Surg. Oncol., February 1, 2006; 13(2): 142 - 149. [Full Text] [PDF]

				K. Thaler, S. Kanneganti, Y. Khajanchee, C. Wilson, L. Swanstrom, and P. D. Hansen The Evolving Role of Staging Laparoscopy in the Treatment of Colorectal Hepatic Metastasis Arch Surg, August 1, 2005; 140(8): 727 - 734. [Abstract] [Full Text] [PDF]

				R. S. Chamberlain Editorial: Laparoscopic Placement of Hepatic Arterial Pumps: A True Advance or a Lot of Effort for a Procedure with a Diminishing Role? Ann. Surg. Oncol., June 1, 2004; 11(6): 558 - 559. [Full Text] [PDF]